# LEVOLEUCOVORIN CALCIUM
> **ANDA217314** · Abbreviated New Drug Application (Generic) · Sponsor: HAINAN POLY PHARM · Approved 2023-05-22
## Drug
- **FDA Application Number:** ANDA217314
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOLEUCOVORIN CALCIUM
- **Generic name:** LEVOLEUCOVORIN INJECTION
- **Active ingredients:** LEVOLEUCOVORIN CALCIUM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HAINAN POLY PHARM
- **Manufacturer:** Hainan Poly Pharm. Co., Ltd.
- **First approval:** 2023-05-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217314)
---
*AI Analytics · CC0 1.0*